سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

The possible involvement of miR-34 in cancer treatment

Publish Year: 1403
Type: Journal paper
Language: English
View: 62

This Paper With 7 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_TBSRJ-6-4_004

Index date: 3 December 2024

The possible involvement of miR-34 in cancer treatment abstract

Cancer is one of the major causes of morbidity and mortality worldwide, resulting from complex interactions between genetic, epigenetic and environmental factors. In the present study, the multifaceted nature of cancer, epidemiology, pathogenesis, and the complex role of genes and microRNAs in the development and progression of tumors have been investigated. We delved into the importance of oncogenes and tumor suppressor genes, especially the pivotal role of the p53 gene in cell cycle regulation and DNA repair mechanisms. In addition, in the current study, the therapeutic potential of microRNAs, especially miR-34, in overcoming chemotherapy resistance and Increasing the effectiveness of treatment has been discussed. By understanding these underlying mechanisms, we aim to provide insight into innovative cancer prevention and treatment strategies.

The possible involvement of miR-34 in cancer treatment Keywords:

The possible involvement of miR-34 in cancer treatment authors

Melika Izadpanah

tabriz university of medical sciences

Oyinkansola Adebomojo

Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN, USA. ۲. Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, IN, USA.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Horgan D, Mia R, Erhabor T, Hamdi Y, Dandara C, ...
Fu J, Imani S, Wu M-Y, Wu R-C. MicroRNA-۳۴ family ...
Kanwal R, Gupta S. Epigenetic modifications in cancer. Clinical genetics. ...
Vannini I, Fanini F, Fabbri M. Emerging roles of microRNAs ...
Saini A, Kumar M, Bhatt S, Saini V, Malik A. ...
DeVita VT, Lawrence TS, Rosenberg SA. Cancer: principles & practice ...
Hartl M, Bader A, Bister K. Molecular targets of the ...
Crespo P, Leon J. Ras proteins in the control of ...
Gocek E, Moulas AN, Studzinski GP. Non-receptor protein tyrosine kinases ...
Patil MR, Bihari A. A comprehensive study of p۵۳ protein. ...
Karimian A, Ahmadi Y, Yousefi B. Multiple functions of p۲۱ ...
Amani J, Gorjizadeh N, Younesi S, Najafi M, Ashrafi AM, ...
Seidel C, Florean C, Schnekenburger M, Dicato M, Diederich M. ...
Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, ...
Croce CM. Causes and consequences of microRNA dysregulation in cancer. ...
Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, ...
Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. ...
Qiu T, Zhou X, Wang J, Du Y, Xu J, ...
Osaki M, Takeshita F, Sugimoto Y, Kosaka N, Yamamoto Y, ...
Hayden EC. Cancer complexity slows quest for cure. Nature. ۲۰۰۸;۴۵۵(۷۲۱۰):۱۴۸ ...
Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, ...
Broderick JA, Zamore PD. MicroRNA therapeutics. Gene therapy. ۲۰۱۱;۱۸(۱۲):۱۱۰۴-۱۰ ...
Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in ...
Bader AG, Brown D, Winkler M. The promise of microRNA ...
Wang L, Yu J, Xu J, Zheng C, Li X, ...
Welponer H, Tsibulak I, Wieser V, Degasper C, Shivalingaiah G, ...
Corney DC, Hwang CI, Matoso A, Vogt M, Flesken-Nikitin A, ...
Nagy Á, Munkácsy G, Győrffy B. Pancancer survival analysis of ...
Chen S, Mao Y, Chen W, Liu C, Wu H, ...
Kim JS, Kim EJ, Lee S, Tan X, Liu X, ...
Zeng Z, Chen X, Zhu D, Luo Z, Yang M. ...
Krajewska JB, Fichna J, Mosińska P. One step ahead: miRNA-۳۴ ...
Deng X, Zheng H, Ke X, Deng M, Ma Z, ...
Hashemi M, Danesh H, Bizhani F, Narouie B, Sotoudeh M, ...
نمایش کامل مراجع